Evaluation of Antihyperlipidemic and Antidiabetic Activity of Phyllanthus emblica L. Fruits doi.org/10.26538/tjnpr/v5i4.13
Main Article Content
Abstract
Phyllanthus emblica L. fruit is used traditionally as medicine for diarrhea, thrush, and cholesterol and it has been studied that Phyllanthus emblica L. fruit have various secondary metabolites such as alkaloids, saponins, flavonoids, tannins, steroids/triterpenoids, glycosides and it also contains high vitamin C, which has anti-cholesterol and anti-diabetic effect. The purpose of the research was to evaluate the anti-cholesterol and anti-diabetic activity of ethanol extract of P. emblica fruit. The extract was obtained by percolation with 96% ethanol solvent. The anti-cholesterol activity was carried out using the Lieberman-Burchard method while the anti-diabetic activity was assessed using the alpha-glucosidase inhibitory activity assay. The determination of the anti-cholesterol activity of the ethanol extract of P. emblica, fenofibrate and simvastatin was carried out at serial concentrations (12.5; 15; 17.5; 20; and 22.5 µg/mL). Ethanol extract of P. emblica fruit reduce cholesterol level by 67.2608; 68.6076; 69.9194; 72.0773 and 73.4992% at 12.5; 15; 17.5; 20; and 22.5 µg/mL, respectively. Fenofibrate showed anti-cholesterol activity with percentage reduction of 58.9696; 61.3529; 62.5344; 64.1717 and 65.8890% while Simvastatin showed anti-cholesterol activity with percentage reduction of 61.1326; 65.0278; 69.2285; 73.3339 and 76.3781% at 12.5; 15; 17.5; 20; and 22.5 µg/mL, espectively. The IC50 values for alpha-glucosidase inhibition for P. emblica extract, acarbose and quercetin were 4.5833; 9.6862 and 2.4850 µg/mL, respectively. It can be concluded that the ethanol extract of P. emblica fruit has anti-cholesterol activity that is similar to simvastatin and it showed higher activity than fenofibrate and it also showed higher antidiabetic activity than acarbose.
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
References
Ali MY, Sina AA, Khandker SS, Neesa L, Tanvir EM, Kabir A, Khalil MI, Gan SH. Nutritional Composition and Bioactive Compounds in Tomatoes and Their Impact on Human Health and Disease: A Review. Foods. 2021; 10(1):45.
Lordan R, Tsoupras A, Mitra B, Zabetakis I. Dairy fats and cardiovascular disease: do we really need to be concerned?. Foods. 2018; 7(3):29.
Gitt AK, Lautsch D, Ferrières J, De Ferrari GM, Vyas A, Baxter CA, Bash LD, Ashton V, Horack M, Almahmeed W, Chiang FT. Cholesterol target value attainment and lipid-lowering therapy in patients with stable or acute coronary heart disease: results from the Dyslipidemia International Study II. Atheroscl. 2017; 266:158-166.
Belete R, Ataro Z, Abdu A, Sheleme M. Global prevalence of metabolic syndrome among patients with type I diabetes mellitus: a systematic review and meta-analysis. Diabetol Metab Syndr. 2021; 13(1):1-3.
Hasan MR, Islam MN, Islam MR. Phytochemistry, pharmacological activities and traditional uses of Emblica
officinalis: A review. Int Curr Pharm J. 2016; 5(2):14-21.
Kanthe PS, Patil BS, Bagali SC, Reddy RC, Aithala MR, Das KK. Protective effects of ethanolic extract of Emblica officinalis(amla) on cardiovascular pathophysiology of rats, fed with high fat diet. J Clin Diagn Res. 2017; 11(9):CC05.
Kanthe PS, Patil BS, Aithala MR, Das KK. Effect of ethanolic extract of Emblica officinalis (amla) on glucose homeostasis in rats fed with high fat diet. J. Krishna Inst. Med Sci Univ. 2017; 6(3):31-7.
Priya FF and Islam MS. Phyllanthus emblica Linn.(Amla)—A Natural Gift to Humans: An Overview. J Dis Med Plants. 2019; 5:1-9.
Suzery M, Isnaning CA, Cahyono B. Potential of kemloko fruit extract and fraction (Phyllanthus emblica L.) as a source of antioxidants. Organic Chemistry Laboratory, Department of Chemistry, Faculty of Science and Mathematics, Diponegoro University. 2017; 167-177p.
Osman H and Yap KC. Comparative sensitivities of cholesterol analysis using GC, HPLC and spectrophotometric methods. Malaysian J Anal Sci. 2006; 10(2):205-10.
Ortiz-Andrade RR, Garcia-Jimenez S, Castillo-Espana P, Ramirez-Avila G, Villalobos-Molina R, Estrada-Soto S. α-Glucosidase inhibitory activity of the methanolic extract from Tournefortia hartwegiana: an anti-hyperglycemic agent. J Ethnopharmacol. 2007; 109(1):48-53.
Yang B, Kortesniemi M, Liu P, Karonen M, Salminen JP. Analysis of hydrolyzable tannins and other phenolic compounds in emblic leaf flower (Phyllanthus emblica L.) fruits by high performance liquid chromatography–electrospray ionization mass spectrometry. J Agric Food Chem. 2012; 60(35):8672-83.
Bashir AS, Mushtaq AA, Mehboob TO. Evaluation of antioxidant and Antidiabetic activity of Phyllanthus emblica(fruit). Biologia Pakistan. 2018; 64(1):85-91.
Kris-Etherton PM, Hecker KD, Bonanome A, Coval SM, Binkoski AE, Hilpert KF, Griel AE, Etherton TD. Bioactive compounds in foods: their role in the prevention of cardiovascular disease and cancer. Am J Med. 2002; 113(9):71-88.